Medicine put to the test

The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients. We provide information about the advantages and disadvantages of examination and treatment methods in the form of scientific reports and easily understandable health information.

Latest news

Press Releases

Press Releases

Between scalpel and algorithm - evidence-based surgery: the IQWiG Autumn Symposium

2019-09-11 Surgery also needs good evidence: How can the surgically relevant research questions best be tackled? We will discuss this on 29 and 30 November.

read more Link to \Between scalpel and algorithm - evidence-based surgery: the IQWiG Autumn Symposium\""

Dacomitinib in advanced lung cancer: large number of disadvantages outweighs survival advantage

2019-08-01 Longer survival is offset by more frequent – and partly severe – side effects and deterioration in symptoms and quality of life. Overall, an added benefit is not proven.

read more Link to \Dacomitinib in advanced lung cancer: large number of disadvantages outweighs survival advantage\""

Ezetimibe reduces the risk of heart attacks and strokes

2019-07-26 Given in addition to statin therapy, ezetimibe has a preventive effect in patients with CHD and acute coronary syndrome.

read more Link to \Ezetimibe reduces the risk of heart attacks and strokes\""

Early benefit assessment reveals weaknesses in the development of new drugs

2019-07-11 In the British Medical Journal, IQWiG researchers analyse the first 216 AMNOG assessments of new drugs and derive proposals for more targeted drug development.

read more Link to \Early benefit assessment reveals weaknesses in the development of new drugs\""

Stem cell transplantation: chance of survival increases with number of procedures

2019-07-02 For other important outcomes, studies are less informative, the correlation is unclear or data are missing. IQWiG presents the first of overall 8 reports on evidence for minimum volumes.

read more Link to \Stem cell transplantation: chance of survival increases with number of procedures\""

Tumour treating fields in glioblastoma: indication of a benefit

2019-06-25 The additional application of the new treatment method prolongs survival, as a recent study shows. However, it can also be burdensome for patients.

read more Link to \Tumour treating fields in glioblastoma: indication of a benefit\""

Fingolimod: advantages for children and adolescents with highly active RRMS requiring treatment switch

2019-06-21 New analyses in an addendum confirm hint of an added benefit in one of four research questions. Especially with regard to quality of life, usable data are now available.

read more Link to \Fingolimod: advantages for children and adolescents with highly active RRMS requiring treatment switch\""

16th HTAi Annual Meeting 2019, Cologne: international experts look into the future of HTA

2019-06-04 In two weeks' time, the 16th HTAi Annual Meeting will start in Cologne: globalization and digitalization also call for adequate methods and effective action in health technology assessment. IQWiG is a…

read more Link to \16th HTAi Annual Meeting 2019, Cologne: international experts look into the future of HTA\""

Allogeneic stem cell transplantation in non-Hodgkin lymphoma: benefit remains unclear

2019-05-21 Meaningful studies are lacking for certain patient groups. Disease-specific registries could help close the data gap.

read more Link to \Allogeneic stem cell transplantation in non-Hodgkin lymphoma: benefit remains unclear\""

Nivolumab with ipilimumab: drug combination has added benefit in advanced renal cell carcinoma

2019-05-15 There are advantages in overall survival, which are not offset by any disadvantages of similar importance. Extent of the added benefit depends on the patient risk scores.

read more Link to \Nivolumab with ipilimumab: drug combination has added benefit in advanced renal cell carcinoma\""

Blister packaging for drugs in nursing homes: much discussed, but hardly investigated

2019-05-14 Data are lacking for arguments on the pros and cons, as the available studies examine the outpatient sector. IQWiG proposes a design for a new study.

read more Link to \Blister packaging for drugs in nursing homes: much discussed, but hardly investigated\""

Current commenting procedures (Hearings)

Current commenting procedures (Hearings)

There are no actual comments.


Calls for tenders advertised

Calls for tenders advertised

In general, calls for tenders are published in German. Interested parties can check current calls for tenders on the German website.


Easily understandable information for patients and the general community

How can I find support groups and information centers?

In Germany, in addition to doctor's offices and hospitals, there is also a wide range of different services for individual counseling and support if you are ill. There are many regional differences in how these services are organized, and they are not always easy to find. You can use this list to help find and make use of local services.   read more (Link to \How can I find support groups and information centers?\"" ‚Äì opens in a new window)


Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close